Cargando…
Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
Oncoproteomics is an important innovation in the early diagnosis, management and development of personalized treatment of acute lymphoblastic leukaemia (ALL). As inherent factors are not completely known – e.g. age or family history, radiation exposure, benzene chemical exposure, certain viral expos...
Autores principales: | López Villar, Elena, Wang, Xiangdong, Madero, Luis, Cho, William C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288348/ https://www.ncbi.nlm.nih.gov/pubmed/25537633 http://dx.doi.org/10.1111/jcmm.12507 |
Ejemplares similares
-
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities
por: López Villar, Elena, et al.
Publicado: (2014) -
Contribution of oncoproteomics to cancer biomarker discovery
por: Cho, William CS
Publicado: (2007) -
Oncoproteomic profiling with antibody microarrays
por: Alhamdani, Mohamed SS, et al.
Publicado: (2009) -
Metastasis-Associated Cell Surface Oncoproteomics
por: Karhemo, Piia-Riitta, et al.
Publicado: (2012) -
Genomic and oncoproteomic advances in detection and treatment of colorectal cancer
por: McHugh, Seamus M, et al.
Publicado: (2009)